Comparison of Clinical Outcomes of Small-incision Lenticule Extraction (SMILE) Between Different Cap Thickness.

October 15, 2020 updated by: Yonsei University

In the past two decades, the femtosecond laser (FSL) technology has been introduced in the corneal refractive surgery filed, and brought a remarkable innovation. It can make tissue dissection through photodisruption and plasma cavitation. Initially, the FSL was used predominantly to make a corneal flap when performing laser in situ keratomileusis (LASIK), which is followed by stromal ablation using excimer laser. A new surgical technique called femtosecond lenticule extraction (FLEx) has been developed that uses only FSL to dissect two interfaces to create refractive lenticule and then remove it, which is very similar with LASIK. Small incision lenticule extraction (SMILE) which is the advanced form of all-in-one FSL refractive technique does not make a corneal flap rather make small incision where the separated refractive lenticule is removed through, and the upper part of the corneal tissue is called cap. Since the clinical outcomes of SMILE were firstly published in 2011, SMILE has been widely used for correction of myopia or myopic astigmatism worldwide. SMILE provides excellent visual outcomes and has advantages including a lesser decrease in corneal sensitivity and absence of flap related complications compared to LASIK.

Because corneal ectasia after refractive surgery is the one of most terrifying complication, corneal biomechanics has been drawn interests to many researchers and clinicians. Theoretically, SMILE may preserve corneal biomechanics better than LASIK, because the anterior stroma which is stiffer than the posterior stroma remains intact in SMILE. However, there are some controversies, because previous studies investigating corneal biomechanics have been reported inconsistent outcomes, although SMILE has been reported equal to or better than LASIK. Weakening of corneal biomechanics and iatrogenic corneal ectasia have also been reported after SMILE. In addition, because the tensile strength of cornea gradually decreases as it goes backwards, creating deeper refractive lenticule may result in stronger cornea by preserving more of anterior lamellae of the cornea. But on the contrary, leaving sufficient residual stromal bed has been known to be important in preventing iatrogenic corneal ectasia, hence creating thin cap may be effective and desirable. Although many researches have been investigated the difference in biomechanical response between SMILE and LASIK, there are few studies evaluating the dependence of cap thickness on postoperative biomechanical strength after SMILE. El-Massry et al. reported that the thicker cap thickness showed higher postoperative corneal hysteresis (CH) and corneal resistance factor (CRF) with Ocular Response Analyzer (ORA; Reichert Ophthalmic Instruments, Depew, NY) which may not be optimal for a clear description of the viscosity and elasticity of the cornea,3 ; however, other studies have been presented that there is no significant difference of corneal biomechanics with cap thickness. There is no comparative human study using Corvis ST (Oculus, Wetzlar, Germany) despite presence of the study using Corvis ST in rabbit eyes. Furthermore, no prospective study with large number of subjects has been performed to date.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 03722
        • Department of Ophthalmology, Yonsei Univeristy College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age of 20 years or older.
  2. Myopia
  3. Who is willing to get SMILE surgery

Exclusion Criteria:

  1. severe ocular surface disease
  2. any corneal disease, cataract, glaucoma, macular disease, or previous history of intraocular or corneal surgery
  3. Patients with suspicion of keratoconus on corneal topography

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: 120 μm group
The subjects underwent SMILE using 120 μm cap.
The surgery was performed with standardized techniques with triple centration technique using the 500-KHz VisuMax system (Carl Zeiss Meditec AG, Jena, Germany). The superior cap depth was set as 120 or 140 µm, and the length of the side cut was set to 2 mm. Once the anterior (upper) and posterior (lower) planes of the lenticule were defined, the anterior and posterior interfaces were dissected using a micropetala with a blunt circular tip and extracted with midforceps. The integrity of the lenticule was assessed subsequently.
ACTIVE_COMPARATOR: 140 μm group
The subjects underwent SMILE using 140 μm cap.
The surgery was performed with standardized techniques with triple centration technique using the 500-KHz VisuMax system (Carl Zeiss Meditec AG, Jena, Germany). The superior cap depth was set as 120 or 140 µm, and the length of the side cut was set to 2 mm. Once the anterior (upper) and posterior (lower) planes of the lenticule were defined, the anterior and posterior interfaces were dissected using a micropetala with a blunt circular tip and extracted with midforceps. The integrity of the lenticule was assessed subsequently.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uncorrected Distance Vision Acuity
Time Frame: from preoperative to postoperative 6 months
Uncorrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
from preoperative to postoperative 6 months
Corrected Distance vision Acuity
Time Frame: from preoperative to postoperative 6 months
Corrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
from preoperative to postoperative 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1.Total higher order aberration at each time point between the two groups.
Time Frame: from preoperative to postoperative 6 months

Total higher order aberrations, spherical aberrations, and coma aberrations are examined using Keratron Scout (Optikon 2000, Rome, Italy). The unit of those is "μm".

1,2. Total higher order aberrations at each time point and change from baseline at each time point will be compared between the two groups.

from preoperative to postoperative 6 months
2.Total higher order aberration changes from baseline at each postoperative time point between the two groups.
Time Frame: from preoperative to postoperative 6 months

Total higher order aberrations, spherical aberrations, and coma aberrations are examined using Keratron Scout (Optikon 2000, Rome, Italy). The unit of those is "μm".

1,2. Total higher order aberrations at each time point and change from baseline at each time point will be compared between the two groups.

from preoperative to postoperative 6 months
3.Spherical aberration at each time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
3,4. Spherical aberrations at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months
4.Spherical aberration changes from baseline at each postoperative time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
3,4. Spherical aberrations at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months
5.Coma aberration at each time point between the two groups.
Time Frame: from preoperative to postoperative 6 months

5,6. Coma aberrations at each time point and change from baseline at each time point will be compared between the two groups.

Corneal biomechanics including deformation amplitude ratio (DA ratio), and stiffness parameter at first applanation (SP-A1) is examined using Corvis ST (Oculus, Wetzlar, Germany). The unit of SP-A1 is "mm Hg/mm", and DA ratio is unitless.

from preoperative to postoperative 6 months
6.Coma aberration changes from baseline at each postoperative time point between the two groups.
Time Frame: from preoperative to postoperative 6 months

5,6. Coma aberrations at each time point and change from baseline at each time point will be compared between the two groups.

Corneal biomechanics including deformation amplitude ratio (DA ratio), and stiffness parameter at first applanation (SP-A1) is examined using Corvis ST (Oculus, Wetzlar, Germany). The unit of SP-A1 is "mm Hg/mm", and DA ratio is unitless.

from preoperative to postoperative 6 months
7.Deformation amplitude ratio (DA ratio) at each time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
7,8 DA ratio at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months
8.DA ratio changes from baseline at each postoperative time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
7,8 DA ratio at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months
9.Stiffness parameter at first applanation (SP-A1) at each time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
9,10 SP-A1 at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months
10.SP-A1 changes from baseline at each postoperative time point between the two groups.
Time Frame: from preoperative to postoperative 6 months
9,10 SP-A1 at each time point and change from baseline at each time point will be compared between the two groups.
from preoperative to postoperative 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 18, 2017

Primary Completion (ACTUAL)

August 26, 2019

Study Completion (ACTUAL)

August 26, 2019

Study Registration Dates

First Submitted

June 19, 2018

First Submitted That Met QC Criteria

June 28, 2018

First Posted (ACTUAL)

July 12, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 19, 2020

Last Update Submitted That Met QC Criteria

October 15, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-2017-0063

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on SMILE using 120μm cap thickness

Subscribe